Zhejiang Huahai Pharmaceutical Co Ltd (600521) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.029x

Based on the latest financial reports, Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥282.81 Million ≈ $41.38 Million USD) by net assets (CN¥9.60 Billion ≈ $1.40 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Zhejiang Huahai Pharmaceutical Co Ltd (600521) total market value for the company's overall valuation and market capitalisation.

Zhejiang Huahai Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Zhejiang Huahai Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Huahai Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Huahai Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Zhejiang Huahai Pharmaceutical Co Ltd to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Palomar Holdings Inc
NASDAQ:PLMR
0.095x
PTT OIL+RET.BUS.-NVDR- 10
F:7F80
0.185x
Shaanxi Sirui Advanced Materials Co. Ltd. A
SHG:688102
N/A
Fielmann Aktiengesellschaft
XETRA:FIE
0.243x
Cal-Maine Foods Inc
NASDAQ:CALM
0.002x
Hoegh Autoliners ASA
OL:HAUTO
0.458x
Uni-President China Holdings Ltd
F:58U
0.031x
AXIA Energia
NYSE:AXIA
0.039x

Annual Cash Flow Conversion Efficiency for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Huahai Pharmaceutical Co Ltd from 2001 to 2025. View 600521 live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥9.46 Billion
≈ $1.38 Billion
CN¥1.23 Billion
≈ $180.00 Million
0.130x -45.99%
2024-12-31 CN¥9.02 Billion
≈ $1.32 Billion
CN¥2.17 Billion
≈ $317.93 Million
0.241x -10.35%
2023-12-31 CN¥8.25 Billion
≈ $1.21 Billion
CN¥2.22 Billion
≈ $324.42 Million
0.269x +67.47%
2022-12-31 CN¥7.75 Billion
≈ $1.13 Billion
CN¥1.24 Billion
≈ $181.85 Million
0.160x +15.85%
2021-12-31 CN¥6.78 Billion
≈ $991.59 Million
CN¥938.43 Million
≈ $137.32 Million
0.138x -40.13%
2020-12-31 CN¥6.72 Billion
≈ $983.95 Million
CN¥1.56 Billion
≈ $227.61 Million
0.231x -23.78%
2019-12-31 CN¥5.78 Billion
≈ $845.61 Million
CN¥1.75 Billion
≈ $256.66 Million
0.304x +1780.57%
2018-12-31 CN¥4.21 Billion
≈ $615.58 Million
CN¥67.90 Million
≈ $9.94 Million
0.016x -85.06%
2017-12-31 CN¥5.05 Billion
≈ $739.67 Million
CN¥546.24 Million
≈ $79.93 Million
0.108x +14.22%
2016-12-31 CN¥4.58 Billion
≈ $669.88 Million
CN¥433.10 Million
≈ $63.38 Million
0.095x +80.21%
2015-12-31 CN¥3.72 Billion
≈ $544.40 Million
CN¥195.31 Million
≈ $28.58 Million
0.052x -47.82%
2014-12-31 CN¥3.27 Billion
≈ $477.93 Million
CN¥328.61 Million
≈ $48.09 Million
0.101x -38.04%
2013-12-31 CN¥3.02 Billion
≈ $441.82 Million
CN¥490.29 Million
≈ $71.75 Million
0.162x +29.80%
2012-12-31 CN¥1.95 Billion
≈ $285.21 Million
CN¥243.83 Million
≈ $35.68 Million
0.125x -3.12%
2011-12-31 CN¥1.53 Billion
≈ $223.82 Million
CN¥197.51 Million
≈ $28.90 Million
0.129x -43.15%
2010-12-31 CN¥1.32 Billion
≈ $192.92 Million
CN¥299.47 Million
≈ $43.82 Million
0.227x -13.25%
2009-12-31 CN¥1.21 Billion
≈ $177.39 Million
CN¥317.44 Million
≈ $46.45 Million
0.262x +243.02%
2008-12-31 CN¥1.10 Billion
≈ $161.41 Million
CN¥84.20 Million
≈ $12.32 Million
0.076x -45.45%
2007-12-31 CN¥975.52 Million
≈ $142.75 Million
CN¥136.52 Million
≈ $19.98 Million
0.140x +57.99%
2006-12-31 CN¥875.40 Million
≈ $128.10 Million
CN¥77.54 Million
≈ $11.35 Million
0.089x +33.34%
2005-12-31 CN¥802.34 Million
≈ $117.41 Million
CN¥53.30 Million
≈ $7.80 Million
0.066x -68.13%
2004-12-31 CN¥785.53 Million
≈ $114.95 Million
CN¥163.73 Million
≈ $23.96 Million
0.208x +201.31%
2003-12-31 CN¥685.42 Million
≈ $100.30 Million
CN¥47.41 Million
≈ $6.94 Million
0.069x -92.60%
2002-12-31 CN¥80.56 Million
≈ $11.79 Million
CN¥75.34 Million
≈ $11.02 Million
0.935x +79.90%
2001-12-31 CN¥72.15 Million
≈ $10.56 Million
CN¥37.51 Million
≈ $5.49 Million
0.520x --

About Zhejiang Huahai Pharmaceutical Co Ltd

SHG:600521 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.50 Billion
CN¥23.94 Billion CNY
Market Cap Rank
#4500 Global
#706 in China
Share Price
CN¥15.99
Change (1 day)
-0.74%
52-Week Range
CN¥14.01 - CN¥27.01
All Time High
CN¥43.62
About

Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production, and sales of generic drugs, biologics, drugs, and specialty active pharmaceutical ingredients in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging componen… Read more